Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

RNA Covid vaccines could have adverse non-specific effects

A new meta-analysis study examining the results from Covid vaccine trials suggests a worrying possibility: that mRNA Covid vaccines, despite protecting against Covid, could reduce the immune system's overall ability to fight infections. On the other hand, the study’s findings also suggest the adenovirus Covid vaccines could have the opposite effect. To many this will sound far-fetched, or even the stuff of conspiracy theory, but University of Southern Denmark’s Professor Christine Stabell-Benn, who led the research, explains to HBI that epidemiologists have known for decades that vaccines can have such ‘nonspecific’ effects and emphasises that regulatory frameworks are in dire need of being updated to reflect this.
June 9, 2022

Interview: Joe Stringer, partner, Octopus Ventures

Joe Stringer, healthcare investment specialist, and partner at Octopus Ventures which invests in and supports start-up businesses across Europe, talks to HBI about his approach to investment ahead of his panel appearance at HBI 2022.
May 13, 2022

Two new rival hospitals open in central London

This week UK healthcare charity Nuffield Trust opened a hospital in its first central London site, located within the grounds of Barts Health NHS Trust’s St Bartholomew’s Hospital site, while Cleveland Clinic last week opened a large facility in Grosvenor Place, also in central London.
May 5, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022

Ardian “looking to sell Inovie stake”

Last week we reported that French lab group Inovie is currently in the process of looking for a new majority shareholder. Could private equity fund Ardian be looking to sell its (minority) stake.
April 13, 2022

Atrys: What’s the focus?

No listed health care group in Europe has grown anything like as fast as Atrys Health, which now spans Spain, Portugal, Switzerland and four Latin American countries. But does its M&A strategy have any coherence? We talk to Atrys CFO Josep Maria Huch.
April 11, 2022

Fresenius Helios launches revolutionary primary care offer

Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.
April 8, 2022

€4bn Inovie looking for majority shareholder

French lab group Inovie is looking for a new majority stakeholder off a €4bn+ enterprise value, HBI hears. Inovie is currently working with financial advisers to determine interest from potential buyers.
April 7, 2022

How can you build a successful health care science cluster in Europe?

Europe, with its often rigorous divides between research institutes and university hospitals, has fallen a long way behind power houses such as MIT/Harvard/Mass General in the generation of applied medical science. So how do you build a successful healthcare science cluster in Europe?
March 24, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us